Applications of Nanobiotechnology for Neglected Tropical Diseases

Fabio Rocha Formiga graduated in pharmaceutical sciences, obtaininghis bachelor’s degree in 2004 from the Federal University of Rio Grande doNorte, Brazil, where he also concluded a master’s course in health sciences.In 2011, he obtained a PhD in pharmaceutical technology from the Universityof Navarra in Spain, with distinctions, as a MAEC-AECID scholar. In 2018,he completed a research training in nanobiomaterials at the Rice University(Houston, United States). Dr. Formiga has worked as a visiting professor atthe University of Coimbra, Portugal. He has experience in teaching/supervisionat the BSc, MSc, and PhD levels. In addition, he has acted as referee fornational and foreign funding agencies. He has participated as a member of universitycommittees, examination boards, and has organized scientific meetings,including the 22nd International Symposium on Microencapsulation (Chair).Dr. Formiga has also been strongly involved in collaborative programs for exchangewith European universities (from Portugal, Spain, and Denmark). He isa cofounder and vice-president of the Brazilian Chapter of Controlled ReleaseSociety (CRS, 2019–present) and guest associate editor of the Drug Deliveryand Translational Research (Springer) and Pharmaceutical Nanotechnology(Bentham). He is a member of the Brazilian Association of PharmaceuticalSciences (ABCF) and the European Foundation for Clinical Nanomedicine(CLINAM). Currently, Dr. Formiga is a research scientist and deputy head ofthe Department of Immunology at the Aggeu Magalhães Institute, OswaldoCruz Foundation (FIOCRUZ), Brazil. He also holds a tenured adjunct professorposition at University of Pernambuco (UPE). Dr. Formiga was acknowledgedwith the Research Award from Spanish Society of Pharmaceutics andPharmaceutical Technology (SEFIG) in 2013 and the Benjamin Gilbert Award from FIOCRUZ in 2017. His research has focused on pharmaceutics, drug delivery,nanotechnology, and biomaterials toward neglected tropical diseases andregenerative medicine. Dr. Inamuddin, is an Assistant professor at Department of Applied Chemistry, Zakir Husain College of Engineering and Technology, Faculty of Engineering and Technology, Aligarh Muslim University, Aligarh, India. He has extensive research experience in multidisciplinary fields of analytical chemistry, materials chemistry, electrochemistry, renewable energy and environmental science. He has worked on different research projects funded by various government agencies and universities and is the recipient of awards, including the Fast-Track Young Scientist Award and young researcher of the year award-2020 of the university. His current research interests include ion exchange materials, a sensor for heavy metal ions, biofuel cells, supercapacitors and bending actuators. Dr. Severino is currently working as a professor in the College of Pharmacyand Postgraduate Program in Industrial Biotechnology, Tiradentes University(UNIT), Aracaju, Brazil and is also a research coordinator of Nanomedicineand Nanotechnology Laboratory Institute of Technology and Research (ITP),Aracaju, Brazil. She graduated in pharmacy from the Methodist University ofPiracicaba—Unimep (2005). She earned master’s and PhD from the Facultyof Chemical Engineering at the State University of Campinas—Unicamp(2008 and 2012). In the master's she carried out a sandwich program at theFaculty of Pharmacy of the Federal University of Rio Grande do Sul—UFRGS(2007–08), and in her PhD carried out a sandwich program at the Faculty ofPharmacy of the Fernando Pessoa University—UFP, Porto, Portugal (2010–11).She has extensive research experience in multidisciplinary fields of nanomedicine,biomaterial, drug delivery, cosmetics, and biotechnology. She haspublishedabout 110 research articles in various international scientific journals,24 book chapters, and 16 patents. She is a member of editorial boards of variousjournals. She has worked in technical-scientific collaboration with researchersfrom different institutions in the country and abroad, such as the United States,England, the Czech Republic, EUA, Italy, Turkey, India, and Portugal. She is aCNPq research productivity scholar (PQ-2). Currently, she is working in the internationalizationprocess of UNIT at the Tiradentes Institute (TI-UMass) and isa visiting professor at Brigham and Women’s Hospital/Harvard Medical School,Cambridge, Massachusetts, United States.

• Part I: Nano-based approaches for prevention of NTD1. Experimental vaccination with nanoparticles containing Escherichia coli virulence factors2. Vaccine as immunotherapy for leishmaniasis3. Polymeric particles as a delivery agent for malarial vaccinesPart II: Nano-Diagnostics and Detection of NTD4. The use of nano-enabled technologies to diagnose dengue virus infections 5. Multiplexed detection with nanodiagnostics6. Nanosensor for the detection of malaria parasite Part III: Nanotherapeutics for NTD7. Developing effective amphotericin B delivery systems for fungal infections8. Development of nanocarriers for innovative antimalarial combination strategies9. Nanomedicines against Chagas disease10. Nanoformulations of old and new antimalarial drugs11. Drug repurposing and nanoparticles: New strategies against leishmaniasis12. Nanoformulations for new compounds against leishmaniasis13. Improving the miltefosine efficacy against leishmaniasis by using nanoassemblies made from surfactants or amphiphilic antimony (V) complex14. Trendings of amphotericin B-loaded nanoparticles as valuable chemotherapeutic approaches against leishmaniasis15. Nanopharmaceuticals to target antifilarials: Administration of old age drugs in a novel way16. Lipid nanoparticles for the treatment of neglected tropical diseases17. Experimental treatment of Schistosomiasis mansoni using praziquantel-free and encapsulated into nanostructuresPart IV: Other approaches for NTD18. Bionanocomposite assembly with larvicidal activity against Aedes aegypti19. Microfilaricidal efficacy of silver nanoparticles20. Self-assembled nanocarriers as biotechnology approach to antivenom immunotherapy21. Novel processes combining natural products and synthetic materials for developing nanolarvicides22. Development of eco-friendly nano-mosquitocides against arboviruses vectors23. Systems biology and bioinformatics approaches in leishmaniasis24. May nanoparticles offer chances to avoid the development of insecticide resistance in mosquitoes?